SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+29.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$618M
AUM Growth
+$618M
(+15%)
Cap. Flow
-$43.5M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
114
New
21
Increased
23
Reduced
33
Closed
17
Top Buys
| 1 |
Perspective Therapeutics
CATX
|
$14.8M |
| 2 |
CYBN
Cybin
CYBN
|
$10.6M |
| 3 |
BridgeBio Pharma
BBIO
|
$9.39M |
| 4 |
SentinelOne
S
|
$7.86M |
| 5 |
Outlook Therapeutics
OTLK
|
$6.82M |
Top Sells
| 1 |
Nova
NVMI
|
$17.2M |
| 2 |
Astria Therapeutics
ATXS
|
$14.6M |
| 3 |
Cartesian Therapeutics
RNAC
|
$14.2M |
| 4 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$13.6M |
| 5 |
Tower Semiconductor
TSEM
|
$11.7M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Technology | 18.02% |
| 3 | Communication Services | 3.09% |
| 4 | Consumer Discretionary | 2.82% |
| 5 | Utilities | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $26.7M | 3.75% | 1,889,700 -579,400 | -23% | -$8.18M |
|
2
Sanofi
SNY
$121B
| $24.3M | 3.41% | 499,515 | – | – |
|
3
Nice
NICE
$8.73B
| $22.4M | 3.14% | 85,881 +18,163 | +27% | +$4.73M |
|
4
Cytokinetics
CYTK
$4.23B
| $19.7M | 2.77% | 281,671 +57,851 | +26% | +$4.06M |
|
5
Syndax Pharmaceuticals
SNDX
$1.41B
| $19.3M | 2.72% | 812,964 +40,000 | +5% | +$952K |
|
|
6
BridgeBio Pharma
BBIO
$9.89B
| $18.1M | 2.55% | 585,956 +303,810 | +108% | +$9.39M |
|
7
Biogen
BIIB
$19.4B
| $15.2M | 2.14% | 70,646 +24,300 | +52% | +$5.24M |
|
8
Jasper Therapeutics
JSPR
$45.5M
| $14.8M | 2.08% | 505,242 -207,821 | -29% | -$6.1M |
|
|
9
Perspective Therapeutics
CATX
$250M
| $14.8M | 2.08% | 12,443,621 +12,417,950 | +48,373% | +$14.8M |
|
10
Merck
MRK
$210B
| $13.7M | 1.92% | 103,600 -20,000 | -16% | -$2.64M |
|
11
Kura Oncology
KURA
$686M
| $13M | 1.83% | 610,826 -92,461 | -13% | -$1.97M |
|
12
AstraZeneca
AZN
$248B
| $12.9M | 1.81% | 190,060 +10,000 | +6% | +$678K |
|
|
13
SentinelOne
S
$6.29B
| $12.8M | 1.8% | 550,818 +337,400 | +158% | +$7.86M |
|
14
Johnson & Johnson
JNJ
$427B
| $12.6M | 1.77% | 79,831 | – | – |
|
15
Meta Platforms (Facebook)
META
$1.86T
| $12.4M | 1.74% | 25,439 -8,864 | -26% | -$4.3M |
|
16
Celldex Therapeutics
CLDX
$1.47B
| $11.6M | 1.63% | 276,996 -38,648 | -12% | -$1.62M |
|
17
Microsoft
MSFT
$3.77T
| $11.6M | 1.63% | 27,548 +3,700 | +16% | +$1.56M |
|
18
Ultragenyx Pharmaceutical
RARE
$2.89B
| $11.1M | 1.56% | 238,544 +37,500 | +19% | +$1.75M |
|
19
Eli Lilly
LLY
$657B
| $11M | 1.55% | 14,190 | – | – |
|
20
Praxis Precision Medicines
PRAX
$958M
| $10.8M | 1.52% | 177,139 -151,847 | -46% | -$9.27M |
|
21
Novo Nordisk
NVO
$251B
| $10.7M | 1.5% | 83,080 -10,000 | -11% | -$1.28M |
|
|
CYBN
22
Cybin
CYBN
$176M
| $10.6M | 1.49% | +25,581,395 | New | +$10.6M |
|
|
INZY
23
DELISTED
Inozyme Pharma
INZY
| $10.5M | 1.48% | 1,372,907 -190,000 | -12% | -$1.46M |
|
24
JFrog
FROG
$5.76B
| $9.92M | 1.39% | 224,381 +114,476 | +104% | +$5.06M |
|
25
Amazon
AMZN
$2.44T
| $9.82M | 1.38% | 54,432 -1,244 | -2% | -$224K |
|